{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:04:57Z","timestamp":1743746697068},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.2169\/internalmedicine.3326-19","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T22:04:01Z","timestamp":1572473041000},"page":"739-744","source":"Crossref","is-referenced-by-count":4,"title":["Epidemic Myalgia Associated with Human Parechovirus Type 3 Infection"],"prefix":"10.2169","volume":"59","author":[{"given":"Moemi","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Takayoshi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kawase","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Research Center for Zoonosis Control, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguto","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Yasutomo","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yokono","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Warin JF, Davies JB, Sanders FK, Vizoso AD. Oxford epidemic of Bornholm disease, 1951. Br Med J 20: 1345-1351, 1953.","DOI":"10.1136\/bmj.1.4824.1345"},{"key":"2","unstructured":"2. Williams WO. Bornholm disease survey 1956, 1957 and 1958. J Coll Gen Pract 4: 181-213, 1961."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Romero JR, Modlin JF. Coxsackieviruses, Echoviruses, and numbered Enteroviruses. In: Mandell, Douglas, and Bennett&apos;s principles and practice of infectious diseases. 8th ed. Elsevier, Philadelphia, PA, 2015: 2080-2090.","DOI":"10.1016\/B978-1-4557-4801-3.00174-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mizuta K, Kuroda M, Kurimura M, et al. Epidemic myalgia in adults associated with Human Parechovirus type 3 infection, Yamagata, Japan, 2008. Emerg Infect Dis 18: 1787-1793, 2012.","DOI":"10.3201\/eid1811.111570"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamamoto SP, Kaida A, Naito T, et al. Human parechovirus infections and child myositis cases associated with genotype 3 in Osaka City, Japan, 2014. J Med Microbiol 64: 1415-1424, 2015.","DOI":"10.1099\/jmm.0.000167"},{"key":"6","unstructured":"6. Sano T, Kadekaru S, Watanabe S, et al. Detection of human parechovirus 3 from primary school students and adults with myalgia, June to October 2016-Kanagawa Prefecture. Infect Agents Surveill Rep 38: 127-128, 2017 (in Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stanway G, Joki-Korpela P, Hyypi\u00e4 T. Human parechoviruses-biology and clinical significance. Rev Med Virol 10: 57-69, 2000.","DOI":"10.1002\/(SICI)1099-1654(200001\/02)10:1<57::AID-RMV266>3.0.CO;2-H"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Esposito S, Rahamat-Langendoen J, Ascolese B, Senatore L, Castellazzi L, Niesters HGM. Pediatric parechovirus infections. J Clin Virol 60: 84-89, 2014.","DOI":"10.1016\/j.jcv.2014.03.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and identification of a novel human parechovirus. J Gen Virol 85: 391-398, 2004.","DOI":"10.1099\/vir.0.19456-0"},{"key":"10","unstructured":"10. Harvala H, Wolthers KC, Simmonds P. Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis 23: 224-230, 2010."},{"key":"11","unstructured":"11. de Crom SC, Rossen JWA, van Furth AM, Obihara CC. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr 175: 1023-1029, 2016."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Khatami A, McMullan BJ, Webber M, et al. Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia. Clin Infect Dis 60: 228-236, 2015.","DOI":"10.1093\/cid\/ciu784"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Harvala H, Robertson I, McWilliam EC, et al. Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol 46: 3446-3453, 2008.","DOI":"10.1128\/JCM.01207-08"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Aizawa Y, Saitoh A. Human parechoviruses. Uirusu (Viruses) 65: 17-26, 2015 (in Japanese).","DOI":"10.2222\/jsv.65.17"},{"key":"15","unstructured":"15. Mizuta K, Yamakawa T, Nagasawa H, et al. Epidemic myalgia associated with human parechovirus type 3 infection among adults occurs during an outbreak among children: findings from Yamagata, Japan, in 2011. J Clin Virol 58: 188-193, 2013."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanaka S, Aoki Y, Matoba Y, et al. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol 60: 854-858, 2016.","DOI":"10.1111\/1348-0421.12456"},{"key":"17","unstructured":"17. Nakamura K, Saito K, Hara Y, et al. Severe epidemic myalgia with an elevated level of serum interleukin-6 caused by human parechovirus type 3: a case report and brief review of the literature. BMC Infect Dis 18: 381, 2018."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fisherman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376, 1998.","DOI":"10.1172\/JCI2629"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shinomoto M, Kawasaki T, Sugahara T, et al. First report of human parechovirus type 3 infection in a pregnant woman. Int J Infec Dis 59: 22-24, 2017.","DOI":"10.1016\/j.ijid.2017.03.018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanaka S, Kunishi Y, Ota M, et al. Severe human parechovirus Type 3 infection in adults associated with gastroenteritis in their children. J Infect Dis 49: 772-774, 2017.","DOI":"10.1080\/23744235.2017.1323347"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yamakawa T, Mizuta K, Kurokawa K, et al. Clinical characteristics of 17 adult patients with epidemic myalgia associated with human parechovirus type 3 infection. Clin Neurol 57: 485-491, 2017 (in Japanese).","DOI":"10.5692\/clinicalneurol.cn-001035"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3326-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T12:04:17Z","timestamp":1611662657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3326-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3326-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}